| Cat.No. : |
IL18BP-264H
Optional Service: Optional requirements on this protein
|
| Product Overview : |
Recombinant Human IL18BP (Accession # AAD17190) was produced in Mouse myeloma cell line, NS0-derived. |
| Source : |
Mammalian cells |
| Species : |
Human |
| Tag : |
Fc Chimera |
| Predicted N Terminal : |
Thr29 |
| Form : |
Lyophilized from a 0.2 µm filtered solution in PBS. |
| Bio-activity : |
Measured by its ability to inhibit the IL-18-induced response of KG-1 human acute myelogenous leukemia cells.The ED50 for this effect is typically 0.02 - 0.12 µg/mL in the presence of 40 ng/mL of rhIL-18. |
| Molecular Mass : |
Recombinant Human IL18BP, Fc Chimera has a calculated MW of 44.2 kDa (monomer). In SDS-PAGE migrates as 60-80 kDa, reducing conditions. |
| Purity : |
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Storage : |
Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC). |
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
